)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Invent Medic Sweden
Invent Medic Sweden (IMS) investor relations material
Invent Medic Sweden Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary22 Oct, 2026
Executive summary
Q3 revenue was SEK 1,420k vs SEK 1,818k YoY; pre-tax loss narrowed to SEK 782k from SEK 1,149k, extending the improvement trend.
9M revenue was SEK 5,405k vs SEK 5,648k; pre-tax loss narrowed to SEK 2,432k from SEK 4,088k.
Cost restructuring and the 2026 capital raise strengthened the financial position; focus now shifts to commercial growth and market penetration.
Financial highlights
Q3 gross profit was SEK 1,188k vs SEK 1,442k; total operating costs fell to SEK 2,140k from SEK 2,911k.
9M gross profit was SEK 4,360k vs SEK 4,423k; operating costs declined to SEK 7,674k from SEK 9,596k.
Q3 net loss was SEK 782k vs SEK 1,149k; 9M net loss was SEK 2,432k vs SEK 4,088k.
Q3 operating cash flow was negative SEK 861k vs negative SEK 1,654k; 9M operating cash flow was negative SEK 2,784k vs negative SEK 4,250k.
Outlook and guidance
Priorities are accelerating sales, increasing market presence and developing commercial partnerships to pursue sustainable growth and eventual break-even.
Sweden is the home-market platform; efforts target higher penetration through regional agreements, while international resources focus on markets with greatest potential.
Near-term focus markets include the UK and Norway; longer-term plans include adding products and brands through development, partnerships and/or acquisitions.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Invent Medic Sweden
- Six new Efemia distributors, a 7,000-unit FlowCup order, and a MeCovers LOI advance growth plans.IMS
Investor update - Improved sales and profitability in Q2 2026, supported by a successful 5.6 MSEK rights issue.IMSQ2 2026
- Record sales, improved results, and first positive cash flow mark progress toward profitability.IMSQ1 2026
- Improved margins and reduced losses set the stage for profitable growth after a SEK 2.3M share issue.IMSQ4 2025
- Q3 2025 saw 20% revenue growth, improved margins, and record international orders.IMSQ3 2025
- Net loss reduced, equity ratio strengthened, and Efemia sales surged in key European markets.IMSQ2 2025
- Q3 sales up 63% year-over-year; rights issue boosts growth and financial strength.IMSQ3 2024
- Efemia sales up 40% in H1 2024, narrowing losses but more capital needed for growth.IMSQ2 2024
- Sales and financials improved, with new partnerships and equity strengthening.IMSQ1 2025
Next Invent Medic Sweden earnings date
Q4 202618 Feb, 2027
Invent Medic Sweden
Next Invent Medic Sweden earnings date
Q4 202618 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Invent Medic Sweden is a Swedish medical technology company specializing in developing and marketing products designed to improve quality of life for women. The company's offerings focus on medical devices that address women’s health needs, including solutions for pelvic floor health, incontinence, and other conditions. The company is headquartered in Lund, Sweden, and its shares are listed on the Stockholm Stock Exchange.